APOA1 and rheumatoid arthritis: Taken together, those results suggest that anti-apoA-1 IgG have a CV prognostic value mostly in RA patients, where they are associated with proinflammatory cytokine profile and appear to provide incremental predictive ability over Framingham risk factors.